Clinical Trials Logo

Filter by:
NCT ID: NCT01660724 Completed - Arterial Puncture Clinical Trials

Ultrasound Guided Arterial Puncture

Start date: July 2012
Phase: N/A
Study type: Interventional

The main purpose of the study is to evaluate whether the routine use of ultrasound guided arterial puncture can increase the proportion of patients who only needs one puncture attempt in order to successfully extract enough blood to make an arterial blood gas analysis, when ultrasound guided arterial puncture is compared to conventional arterial puncture technique.

NCT ID: NCT01659723 Completed - Clinical trials for Cystitis, Radio Induced

Radiation Induced Cystitis Treated With Hyperbaric Oxygen - A Randomized Controlled Trial

RICH-ART
Start date: August 2012
Phase: Phase 2/Phase 3
Study type: Interventional

The primary objective of this study is to assess the relief of symptoms after Hyperbaric Oxygen Therapy (HBOT) in patients with late radiation cystitis by having Expanded Prostate cancer Index Composite (EPIC)symptom estimation scale as primary variable. Study hypothesis: - HBOT can reduce or reverse the change or otherwise limit the damage of the bladder function and/or structure, which arose as a result of radiation therapy of cancer in the pelvic region organs. - The effects of HBOT are associated with relief of symptoms that, at least in part, is related to the reduction of the extent of the radiation damage. - Vascular density increases, fibrosis prevalence and inflammatory activity are reduced as a sign of an improved function of the mucosa. - Treatment results of HBOT remains, in whole or in part, during the follow-up (residual effect)

NCT ID: NCT01657565 Completed - Wound Infection Clinical Trials

Appendectomy in Children Performed by Residents in the Era of Laparoscopic Surgery

Start date: January 2006
Phase: N/A
Study type: Observational

Introduction: An increasing proportion of childhood appendicitis is treated with laparoscopic appendectomy (LA). The investigators wanted to elucidate the outcome of childhood appendicitis treated primarily by residents in a university hospital. Material and methods: All children (age<16 years) treated surgically with appendectomy in our department between January 2006 and January 2011 were retrospectively identified. Readmission, reoperation or postoperative length of stay (LOS) exceeding five days were considered as non-satisfactory outcomes.

NCT ID: NCT01657357 Completed - Clinical trials for Total Hip Arthroplasty

Routine Follow up After Total Hip Arthroplasty Prior Periacetabular Osteotomy

Start date: January 2012
Phase: N/A
Study type: Observational

Follow up study of patients, who despite periacetabular osteotomy, need a total hip arthroplasty, to see outcome.

NCT ID: NCT01657162 Completed - Clinical trials for Postmenopausal Osteoporosis

Twenty-Four Month Extension Study of BA058-05-003 (Abaloparatide) in Participants With Osteoporosis

ACTIVExtend
Start date: November 20, 2012
Phase: Phase 3
Study type: Interventional

The purpose of this study is to provide 24 months of standard of care data on participants previously enrolled in Study BA058-05-003 (NCT02653417).

NCT ID: NCT01657097 Completed - Asthma Clinical Trials

Allergic Inflammation in Rhinitis Patients Following Nasal Allergen Challenge

Start date: February 1997
Phase: Phase 4
Study type: Interventional

Allergic rhinitis is a common condition caused by inflammation of nasal mucosa. The study was performed to gain information on this inflammation, including effect of intranasal corticosteroid treatment hereupon and potential influence on the lower airways, ie asthma. The study was randomised, placebo-controlled double-blind in patients, monoallergic to grasspollen, presenting symptoms of rhinitis and asthma during season. Treatment,ie intranasal corticosteroid or placebo, were given four weeks. After two weeks of treatment intranasal allergen challenge was performed. Measurements were performed during the full study period. The study was performed out of pollen season.

NCT ID: NCT01657084 Completed - Epilepsy Clinical Trials

Stopping and Preventing Epileptic Seizures Using a Partial Rebreathing Mask

EpiCapno
Start date: September 2012
Phase: N/A
Study type: Interventional

By enabling a partial rebreathing of expired gas, a moderate respiratory acidosis is induced, without causing hypoxia in the patient. Based on the scientific literature on the subject, the study hypothesis is that the fall in body pH will be able to stop and/or prevent epileptic brain activity.

NCT ID: NCT01656278 Completed - Clinical trials for Arthritis, Rheumatoid

An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis

IMAGINE-RA
Start date: March 2012
Phase: N/A
Study type: Interventional

The purpose of this study is to examine whether an magnetic resonance imaging (MRI) -guided treatment strategy based on a predefined treatment algorithm can prevent progression of erosive joint damage, increase remission rate and improve functional level in the short and long term in patients with rheumatoid arthritis (RA).

NCT ID: NCT01656148 Completed - Multiple Sclerosis Clinical Trials

FAME - Fampyra Outcome Measures Study: a Study of Different Outcome Measures on the Effect of Fampyra

FAME
Start date: June 2012
Phase: Phase 4
Study type: Interventional

Fampridine-SR is registered for the treatment of walking incapacity in MS patients. Two pivotal trials show that app. 40% of MS patients with walking incapacity can improve walking speed averagely 25% when recieving the drug. This has been shown using the Timed 25 Foot Walk Test (T25FW). No effect on cognition and upper limb function has been shown, but this has not been investigated in patients responding to the drug measured by the abovementioned test. The question is if this will be the case and also if another walking test, termed the Six Spot Step Test (SSST), will be more sensitive to the effect of Fampridine-SR. Primary outcome measure is the effect measured by SSST. The hypothesis is that SSST is not less sensitive to the effect of Fampridine-SR than T25FW.

NCT ID: NCT01656057 Completed - Clinical trials for To Assess the Impact of Bile Acids on Human Glukagon-like-peptide-1 Secretion

The Impact of Gall Bladder Emptying and Bile Acids on the Human GLP-1-secretion

Start date: July 2012
Phase: N/A
Study type: Interventional

The last couple of years it has been shown that bile acids not only acts as simple emulsifiers of fat, but constitutes a complex metabolic integrator which not only have an influence on fat digestion and lipid metabolism, but also modulates the energy expenditure in (brown) adipose tissue and muscle tissue. This action is due to stimulation of the receptor TGR5 by bile acids. Recently scientists have discovered that this receptor in rodents is also expressed on the surface of intestinal L-cells (which normally secrets Glucagon-Like Peptide-1 (GLP-1) in response to nutrient stimulation). The stimulation of this receptor has shown a GLP-1 secretion from the intestinal cells which is interesting since GLP-1 has a central role in maintaining normal glucose tolerance and thus blood sugar. Given the above, bile acids has an important impact on intestinal GLP-1 secretion. Whether these scientific findings can be proven in human beings is uncertain. The primary hypothesis is that stimulating gall bladder emptying via Cholecystokinin (CCK) in healthy subjects will result in a significant GLP-1 response. We also hypothesize that adding orally Metformin or a sequestrant ("a bile acid binder") will further enhance this GLP-1 response.